Alessio Cortellini

9.0k total citations · 1 hit paper
130 papers, 1.7k citations indexed

About

Alessio Cortellini is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, Alessio Cortellini has authored 130 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Oncology, 54 papers in Pulmonary and Respiratory Medicine and 26 papers in Hepatology. Recurrent topics in Alessio Cortellini's work include Cancer Immunotherapy and Biomarkers (51 papers), Lung Cancer Treatments and Mutations (26 papers) and Hepatocellular Carcinoma Treatment and Prognosis (24 papers). Alessio Cortellini is often cited by papers focused on Cancer Immunotherapy and Biomarkers (51 papers), Lung Cancer Treatments and Mutations (26 papers) and Hepatocellular Carcinoma Treatment and Prognosis (24 papers). Alessio Cortellini collaborates with scholars based in Italy, United Kingdom and United States. Alessio Cortellini's co-authors include David J. Pinato, Antonio Ghidini, Corrado Ficorella, Giampiero Porzio, Michele Ghidini, Alice Indini, Claudia Angela Maria Fulgenzi, Antonio D’Alessio, Melissa Bersanelli and Lucilla Verna and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Cell.

In The Last Decade

Alessio Cortellini

119 papers receiving 1.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association of Obesity With Survival Outcomes in Patients With Cancer

2021 302 citations Alessio Cortellini et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alessio Cortellini Italy	22	1.1k	426	332	247	226	130	1.7k
Mohamad Bassam Sonbol United States	27	1.1k 1.1×	560 1.3×	435 1.3×	143 0.6×	238 1.1×	133	2.5k
Ezzeldin M. Ibrahim Saudi Arabia	25	1.3k 1.2×	335 0.8×	208 0.6×	199 0.8×	60 0.3×	75	2.1k
Olatunji B. Alese United States	22	1.3k 1.2×	423 1.0×	350 1.1×	72 0.3×	125 0.6×	149	2.1k
Judith de Vos‐Geelen Netherlands	24	1.0k 1.0×	624 1.5×	300 0.9×	187 0.8×	60 0.3×	115	1.7k
Anthony Fields Canada	22	2.0k 1.9×	570 1.3×	290 0.9×	345 1.4×	403 1.8×	45	2.7k
Emmanuel Mitry France	21	1.5k 1.4×	600 1.4×	138 0.4×	231 0.9×	117 0.5×	70	2.1k
Murat Akyol Türkiye	19	511 0.5×	356 0.8×	115 0.3×	253 1.0×	375 1.7×	87	1.7k
Hyeong Su Kim South Korea	24	650 0.6×	615 1.4×	437 1.3×	47 0.2×	140 0.6×	117	1.7k
Mario Bargetzi Switzerland	26	813 0.8×	192 0.5×	324 1.0×	166 0.7×	82 0.4×	91	2.3k

Countries citing papers authored by Alessio Cortellini

Since Specialization

Citations

This map shows the geographic impact of Alessio Cortellini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessio Cortellini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessio Cortellini more than expected).

Fields of papers citing papers by Alessio Cortellini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessio Cortellini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessio Cortellini. The network helps show where Alessio Cortellini may publish in the future.

Co-authorship network of co-authors of Alessio Cortellini

This figure shows the co-authorship network connecting the top 25 collaborators of Alessio Cortellini. A scholar is included among the top collaborators of Alessio Cortellini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessio Cortellini. Alessio Cortellini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cortellini, Alessio, Sai Yendamuri, Eleni Karapanagiotou, et al.. (2025). 415P: Transformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: Insights from the pembrolizumab 5-year global registry. Journal of Thoracic Oncology. 20(3). S241–S241.

Moraes, Francisco Cézar Aquino de, Ludimila Cavalcante, Yu Fujiwara, et al.. (2024). Safety and efficacy of osimertinib in patients with NSCLC and uncommon tumoral EGFR mutations: A systematic review and meta-analysis.. Journal of Clinical Oncology. 42(16_suppl). 8642–8642. 2 indexed citations

Nassar, Amin H., Alexander M. Menzies, Georgina V. Long, et al.. (2024). Safety and efficacy of immune checkpoint inhibitors (ICI) in patients (pts) with pre-existing neurologic autoimmune diseases (NAID) and Parkinson's disease.. Journal of Clinical Oncology. 42(16_suppl). 2653–2653.

Horita, Nobuyuki, et al.. (2024). Association between the occurrence of immune-related adverse events and survival outcomes in patients with cancer treated with perioperative immune checkpoint inhibitors: A systematic review and meta-analysis.. Journal of Clinical Oncology. 42(23_suppl). 39–39. 1 indexed citations

Ricciuti, Biagio, Rohit Thummalapalli, Fabrizio Citarella, et al.. (2024). Clinical outcomes and post-progression retreatment in patients with metastatic NSCLC who complete two years of treatment with immune checkpoint blockade.. Journal of Clinical Oncology. 42(16_suppl). 8633–8633.

Fujiwara, Yu, Francisco Cézar Aquino de Moraes, Natasha B. Leighl, et al.. (2024). Safety and Efficacy of Osimertinib in Patients With Non–Small-Cell Lung Cancer and Uncommon Tumoral Epidermal Growth Factor Receptor Mutations: A Systematic Review and Single-Arm Meta-Analysis. JCO Precision Oncology. 8(8). e2400331–e2400331. 4 indexed citations

Citarella, Fabrizio, Kazuki Takada, Priscilla Cascetta, et al.. (2024). Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung). Journal of Translational Medicine. 22(1). 714–714. 3 indexed citations

Behrouzi, Roya, Alessio Signori, Judith Cave, et al.. (2023). Immunotherapy-related adverse events in real-world patients with advanced non-small cell lung cancer on chemoimmunotherapy: a Spinnaker study sub-analysis. Frontiers in Oncology. 13. 6 indexed citations

Takada, Kazuki, et al.. (2023). Impact of Neoadjuvant Immune Checkpoint Inhibitors on Surgery and Perioperative Complications in Patients With Non–small-cell Lung Cancer: A Systematic Review. Clinical Lung Cancer. 24(7). 581–590.e5. 13 indexed citations

10.

Nardo, Lucia Di, Laura Del Regno, Alessandro Di Stefani, et al.. (2023). The dynamics of circulating tumour DNA (ctDNA) during treatment reflects tumour response in advanced melanoma patients. Experimental Dermatology. 32(10). 1785–1793. 4 indexed citations

11.

Pinato, David J., Xiaoxue Li, Pallavi S. Mishra‐Kalyani, et al.. (2023). Association between antibiotics and adverse oncological outcomes in patients receiving targeted or immune-based therapy for hepatocellular carcinoma. JHEP Reports. 5(6). 100747–100747. 33 indexed citations

12.

Fulgenzi, Claudia Angela Maria, Bernhard Scheiner, Alessandra Gennari, et al.. (2023). Efficacy and safety of frontline systemic therapy for advanced HCC: A network meta-analysis of landmark phase III trials. JHEP Reports. 5(5). 100702–100702. 34 indexed citations

13.

Banna, Giuseppe Luigi, Alessio Signori, Alessandra Curioni‐Fontecedro, et al.. (2022). Systemic therapy for pre-treated malignant mesothelioma: A systematic review, meta-analysis and network meta-analysis of randomised controlled trials. European Journal of Cancer. 166. 287–299. 5 indexed citations

14.

Rebuzzi, Sara Elena, Arsela Prelaj, Alex Friedlaender, et al.. (2022). Prognostic scores including peripheral blood-derived inflammatory indices in patients with advanced non-small-cell lung cancer treated with immune checkpoint inhibitors. Critical Reviews in Oncology/Hematology. 179. 103806–103806. 19 indexed citations

15.

Cortellini, Alessio, Ramón Salazar, Mark Bower, et al.. (2022). Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer. British Journal of Cancer. 127(10). 1787–1792. 5 indexed citations

16.

Pantano, Francesco, Michele Iuliani, Giulia Leanza, et al.. (2022). Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis. Journal of bone oncology. 37. 100459–100459. 15 indexed citations

17.

Cantini, Luca, Giulia Mentrasti, Nicla La Verde, et al.. (2021). 35P Lung cancer diagnosis and continuum of care: How did the COVID-19 outbreak impact? Data from an Italian multicenter study. Journal of Thoracic Oncology. 16(4). S713–S713. 1 indexed citations

18.

Parisi, Alessandro, Alessio Cortellini, Katia Cannita, Melissa Bersanelli, & Corrado Ficorella. (2019). Safe Administration of anti-PD-L1 Atezolizumab in a Patient with Metastatic Urothelial Cell Carcinoma and End-Stage Renal Disease on Dialysis. SHILAP Revista de lepidopterología. 2019. 1–3. 11 indexed citations

19.

Angelucci, Adriano, Simona Delle Monache, Alessio Cortellini, Monica Di Padova, & Corrado Ficorella. (2018). “Vessels in the Storm”: Searching for Prognostic and Predictive Angiogenic Factors in Colorectal Cancer. International Journal of Molecular Sciences. 19(1). 299–299. 29 indexed citations

20.

Cortellini, Alessio, Giampiero Porzio, Eva Katharina Masel, et al.. (2018). The PERSONS score for symptoms assessment in simultaneous care setting: A pilot study. Palliative & Supportive Care. 17(1). 82–86. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact